BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Perera MTP, Bramhall SR. Current status and recent advances of liver transplantation from donation after cardiac death. World J Gastrointest Surg 2011; 3(11): 167-176 [PMID: 22180833 DOI: 10.4240/wjgs.v3.i11.167]
URL: https://www.wjgnet.com/1948-9366/full/v3/i11/167.htm
Number Citing Articles
1
Leigh Anne Dageforde, Irene D. Feurer, C. Wright Pinson, Derek E. Moore. Is liver transplantation using organs donated after cardiac death cost‐effective or does it decrease waitlist death by increasing recipient death?HPB 2013; 15(3): 182 doi: 10.1111/j.1477-2574.2012.00524.x
2
Manuel Abradelo De Usera, Carlos Jiménez Romero, Carmelo Loinaz Segurola, Enrique Moreno González. Liver Transplant With Donated Graft After Controlled Cardiac Death. Current situationCirugía Española (English Edition) 2013; 91(9): 554 doi: 10.1016/j.cireng.2013.12.007
3
In Kap Ko, Li Peng, Andrea Peloso, Charesa J. Smith, Abritee Dhal, Daniel B. Deegan, Cindy Zimmerman, Cara Clouse, Weixin Zhao, Thomas D. Shupe, Shay Soker, James J. Yoo, Anthony Atala. Bioengineered transplantable porcine livers with re-endothelialized vasculatureBiomaterials 2015; 40: 72 doi: 10.1016/j.biomaterials.2014.11.027
4
Caio Ribeiro Melki, João Lucas Ribeiro e Fernandes, Agnaldo Soares Lima. Criterio Meld en la Fila de Transplantes: Impacto en la Mortalidad General y por Grupos DiagnósticosBrazilian Journal of Transplantation 2022; 25(2) doi: 10.53855/bjt.v25i2.454_esp
5
铮先 司. The Literature Review of Progress in Quality Assessment for Donation-after-Cardiac-Death Liver TransplantationAdvances in Clinical Medicine 2018; 8(02): 253 doi: 10.12677/ACM.2018.82043
6
Paolo Muiesan, Simon Fisher. The bile duct in donation after cardiac death donor liver transplantCurrent Opinion in Organ Transplantation 2014; 19(4): 447 doi: 10.1097/MOT.0000000000000106
7
Russell J. Krom, Ian J. Welsby, Matthew Fuller, Andrew S. Barbas, Qimeng Gao, Imran J. Anwar, W. Jonathan Dunkman. Incidence of Postreperfusion Hyperfibrinolysis in Liver Transplantation by Donor Type and Observed Treatment StrategiesAnesthesia & Analgesia 2023; 136(3): 518 doi: 10.1213/ANE.0000000000006302
8
Z. M. Younossi, M. Stepanova, S. Saab, S. Kalwaney, S. Clement, L. Henry, S. Frost, S. Hunt. The impact of type 2 diabetes and obesity on the long‐term outcomes of more than 85 000 liver transplant recipients in the USAlimentary Pharmacology & Therapeutics 2014; 40(6): 686 doi: 10.1111/apt.12881
9
Caio Ribeiro Melki, João Lucas Ribeiro e Fernandes, Agnaldo Soares Lima. Critério Meld na Fila de Transplantes: Impacto na Mortalidade Geral e por Grupos DiagnósticosBrazilian Journal of Transplantation 2022; 25(2) doi: 10.53855/bjt.v25i2.454_pt
10
Nicholas B. Murphy, Sam D. Shemie, Alex Capron, Robert D. Truog, Thomas Nakagawa, Andrew Healey, Teneille Gofton, James L. Bernat, Kathleen Fenton, Kiran K. Khush, Bryanna Schwartz, Stephen P. Wall. Advancing the Scientific Basis for Determining Death in Controlled Organ Donation After Circulatory Determination of DeathTransplantation 2024;  doi: 10.1097/TP.0000000000005002
11
Manuel Abradelo De Usera, Carlos Jiménez Romero, Carmelo Loinaz Segurola, Enrique Moreno González. Trasplante hepático con injerto procedente de donación después de muerte cardiocirculatoria controlada. Situación actualCirugía Española 2013; 91(9): 554 doi: 10.1016/j.ciresp.2013.04.009
12
Caio Ribeiro Melki, João Lucas Ribeiro e Fernandes, Agnaldo Soares Lima. Meld Criteria in the Transplant Waiting List: Impact on Mortality Overall and by Diagnostic GroupsBrazilian Journal of Transplantation 2022; 25(2) doi: 10.53855/bjt.v25i2.454_en